Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steven Oberste

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Antimicrobial Agents and Chemotherapy|December 11, 2019
Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life CycleEric Rhoden, Terry Fei Fan Ng, Ray Campagnoli, et al.
The Pediatric Infectious Disease Journal|August 15, 2017
Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016Imtiaz Hussain, Ondrej Mach, Atif Habib, et al.
The Lancet. Infectious Diseases|January 1, 2016
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trialXavier Sáez-Llorens, Ralf Clemens, Geert Leroux-Roels, et al.
Future Microbiology|September 5, 2019
Poliopolis: pushing boundaries of scientific innovations for disease eradicationPierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challengeCarlos M Pérez-Vélez, Marsha S Anderson, Christine C Robinson, et al.
The Journal of General Virology|December 20, 2005
Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enterovirusesM Steven Oberste, Kaija Maher, Alford J Williams, et al.
Vaccine|July 22, 2014
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infantsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Vaccine|September 26, 2013
Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adultsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Emerging Infectious Diseases|April 1, 2009
Human febrile illness caused by encephalomyocarditis virus infection, PeruM Steven Oberste, Eduardo Gotuzzo, Patrick Blair, et al.
The Journal of Infectious Diseases|December 10, 2016
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge ModelMarc S Collett, Jeffrey R Hincks, Kimberley Benschop, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|December 11, 2019
Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life CycleEric Rhoden, Terry Fei Fan Ng, Ray Campagnoli, et al.
The Pediatric Infectious Disease Journal|August 15, 2017
Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016Imtiaz Hussain, Ondrej Mach, Atif Habib, et al.
The Lancet. Infectious Diseases|January 1, 2016
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trialXavier Sáez-Llorens, Ralf Clemens, Geert Leroux-Roels, et al.
Future Microbiology|September 5, 2019
Poliopolis: pushing boundaries of scientific innovations for disease eradicationPierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challengeCarlos M Pérez-Vélez, Marsha S Anderson, Christine C Robinson, et al.
The Journal of General Virology|December 20, 2005
Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enterovirusesM Steven Oberste, Kaija Maher, Alford J Williams, et al.
Vaccine|July 22, 2014
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infantsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Vaccine|September 26, 2013
Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adultsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Emerging Infectious Diseases|April 1, 2009
Human febrile illness caused by encephalomyocarditis virus infection, PeruM Steven Oberste, Eduardo Gotuzzo, Patrick Blair, et al.
The Journal of Infectious Diseases|December 10, 2016
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge ModelMarc S Collett, Jeffrey R Hincks, Kimberley Benschop, et al.
Pageof 23